ESCO Technologies Inc. Common Stock (NY:ESE)

236.85 +4.75 (+2.05%)

Delayed Quote Updated: 12:58 PM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ESCO Technologies Inc. Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Marijuana Stock Movers For June 30, 2022 ↗

June 30, 2022

GAINERS: Marrone Bio Innovations (NASDAQ:MBII) shares closed up 6.42% at $1.16

Via Benzinga

Cannabis Stock Movers For June 28, 2022 ↗

June 28, 2022

GAINERS: Item 9 Labs (OTC:INLB) shares closed up 16.35% at $0.79

Via Benzinga

Bullish Friday For Marijuana Stocks - Leviathan Natural Prods, Item 9 Labs Among Top Gainers ↗

June 24, 2022

GAINERS: Leviathan Natural Prods (OTC:LVCNF) shares closed up 37.15% at $0.80

Via Benzinga

Recap: ESCO Technologies Q1 Earnings ↗

February 08, 2022

ESCO Technologies (NYSE:ESE) reported its Q1 earnings results on Tuesday, February 8, 2022 at 04:15 PM. Here's what investors need to know about the announcement.

Via Benzinga

Marijuana Stock Movers For June 15, 2022 ↗

June 15, 2022

GAINERS: ReneSola (NYSE:SOL) shares closed up 13.09% at $5.01

Via Benzinga

Bullish Thursday For Marijuana Stocks - Cipher Pharmaceuticals, Cansortium Among Top Gainers ↗

June 02, 2022

GAINERS: Cipher Pharmaceuticals (OTC:CPHRF) shares closed up 43.38% at $1.95

Via Benzinga

Cannabis Stock Gainers And Losers From May 12, 2022 ↗

May 12, 2022

GAINERS: GrowGeneration (NASDAQ:GRWG) shares closed up 16.15% at $4.46

Via Benzinga

Cannabis Stock Movers For May 11, 2022 ↗

May 11, 2022

GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 28.38% at $0.02

Via Benzinga

Cannabis Stock Gainers And Losers From May 10, 2022 ↗

May 10, 2022

GAINERS: Cara Therapeutics (NASDAQ:CARA) shares closed up 23.76% at $9.22

Via Benzinga

Cannabis Stock Movers For May 5, 2022 ↗

May 05, 2022

GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 8.62% at $0.01

Via Benzinga

Bullish Sentiment Across The Cannabis Space - Check Full Movers For May 4, 2022 ↗

May 04, 2022

GAINERS: Nine Energy Service (NYSE:NINE) shares closed up 15.71% at $3.24

Via Benzinga

Marijuana Stock Movers For April 26, 2022 ↗

April 26, 2022

GAINERS: LOSERS: Leviathan Natural Prods (OTC:LVCNF) shares closed down 13.22% at $0.66

Via Benzinga

Cannabis Stock Gainers And Losers From April 8, 2022 ↗

April 08, 2022

GAINERS: Cann Gr (OTC:CNGGF) shares closed up 17.44% at $0.27

Via Benzinga

Cannabis Stock Movers For March 30, 2022 ↗

March 30, 2022

GAINERS: Nine Energy Service (NYSE:NINE) shares closed up 6.93% at $3.55

Via Benzinga

These Are Ten Small Cap Stocks With Strong Buy Recommendations ↗

March 27, 2022

One can reduce some risk by taking into account analyst recommendations. Stocks with strong buy recommendations are more likely to perform better than others. Let’s take a look at ten small cap stocks...

Via Talk Markets

Cannabis Stock Gainers And Losers From March 23, 2022 ↗

March 23, 2022

GAINERS: Rhinomed (OTC:

Via Benzinga

11 Industrials Stocks Moving In Wednesday's Intraday Session ↗

February 09, 2022

Gainers Tritium DCFC (NASDAQ:DCFC) stock increased by 72.9% to $16.49 during Wednesday's regular session. The current volume of 57.6 million shares is 2875.3% of...

Via Benzinga

Cannabis Stock Gainers And Losers From January 26, 2022 ↗

January 26, 2022

GAINERS: Item 9 Labs (OTC:

Via Benzinga

Cannabis Stock Gainers And Losers From January 20, 2022 ↗

January 20, 2022

GAINERS: Icanic Brands (OTC:

Via Benzinga

Earnings Scheduled For February 8, 2022 ↗

February 08, 2022

Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.

Via Benzinga

Esco Technologies Inc (ESE) Q4 2021 Earnings Call Transcript ↗

November 18, 2021

ESE earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

ESCO Technologies: Q4 Earnings Insights ↗

November 18, 2021

ESCO Technologies (NYSE:ESE) reported its Q4 earnings results on Thursday, November 18, 2021 at 04:15 PM. Here's what investors need to know about the announcement. Earnings...

Via Benzinga

Earnings Scheduled For November 18, 2021 ↗

November 18, 2021

Companies Reporting Before The Bell • Alibaba Group Holding (NYSE:BABA) is expected to report quarterly earnings at $1.93 per share on revenue of $32.05 billion....

Via Benzinga

ESCO Technologies Earnings Preview ↗

November 17, 2021

ESCO Technologies (NYSE:ESE) is set to give its latest quarterly earnings report on Thursday, 2021-11-18. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

Return On Capital Employed Overview: ESCO Technologies ↗

August 21, 2021

ESCO Technologies (NYSE:ESE) showed a loss in earnings since...

Via Benzinga

Bearish Wave Dumps Marijuana Stocks - GrowGeneration Sundial Growers And Aurora Cannabis Among Top Cannabis Movers For Today - Tilray Down By 6% ↗

August 13, 2021

GAINERS: Cipher Pharms Inc&nb...

Via Benzinga

Topics Cannabis

Esco Technologies Inc (ESE) Q3 2021 Earnings Call Transcript ↗

August 09, 2021

ESE earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Recap: ESCO Technologies Q3 Earnings ↗

August 09, 2021

Shares of ESCO Technologies (NYSE:ESE) rose after the company reported Q3 results. Quarterly Results Earnings per share decreased 11.84% over the past year to $0.67, which missed...

Via Benzinga

Bullish Sentiment Pumps Up Cannabis Stocks: Tilray, Sundial, Aurora & GrowGen Among Top Cannabis Movers For July 20, 2021 ↗

July 20, 2021

GAINERS: Empower Clinics (OTC:

Via Benzinga

Topics Cannabis

Bearish Sentiment Toward Market: Cannabis Movers For July 19, 2021 ↗

July 19, 2021

GAINERS: Livewell Canada Inc (OTC:

Via Benzinga

Topics Cannabis

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.